- Home
- HSAI vs LNTH Comparison
HSAI vs LNTH Comparison
Compare HSAI & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HSAI | LNTH |
|---|---|---|
| Founded | 2014 | 1956 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.4B |
| IPO Year | 2023 | 2015 |
Fundamental Metrics
Financial Performance| Metric | HSAI | LNTH |
|---|---|---|
| Price | $27.71 | $66.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $31.58 | ★ $78.00 |
| AVG Volume (30 Days) | ★ 2.2M | 936.2K |
| Earning Date | 03-09-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.44 | ★ 2.39 |
| Revenue | $385,835,909.00 | ★ $1,525,933,000.00 |
| Revenue This Year | $55.40 | $0.01 |
| Revenue Next Year | $46.78 | $0.26 |
| P/E Ratio | $65.25 | ★ $26.85 |
| Revenue Growth | ★ 43.17 | 1.95 |
| 52 Week Low | $10.41 | $47.25 |
| 52 Week High | $30.85 | $111.29 |
Technical Indicators
Market Signals| Indicator | HSAI | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 66.78 | 42.48 |
| Support Level | $26.26 | $64.34 |
| Resistance Level | $29.05 | $70.33 |
| Average True Range (ATR) | 1.17 | 1.73 |
| MACD | 0.22 | -0.82 |
| Stochastic Oscillator | 80.08 | 3.16 |
Price Performance
Historical ComparisonAbout HSAI Hesai Group each ADS represents one Class B ordinary share
Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.